全文获取类型
收费全文 | 8022篇 |
免费 | 511篇 |
国内免费 | 51篇 |
专业分类
耳鼻咽喉 | 54篇 |
儿科学 | 219篇 |
妇产科学 | 231篇 |
基础医学 | 1192篇 |
口腔科学 | 172篇 |
临床医学 | 725篇 |
内科学 | 1977篇 |
皮肤病学 | 233篇 |
神经病学 | 934篇 |
特种医学 | 151篇 |
外科学 | 722篇 |
综合类 | 18篇 |
一般理论 | 2篇 |
预防医学 | 602篇 |
眼科学 | 97篇 |
药学 | 504篇 |
中国医学 | 18篇 |
肿瘤学 | 733篇 |
出版年
2024年 | 8篇 |
2023年 | 116篇 |
2022年 | 213篇 |
2021年 | 376篇 |
2020年 | 254篇 |
2019年 | 297篇 |
2018年 | 323篇 |
2017年 | 236篇 |
2016年 | 283篇 |
2015年 | 324篇 |
2014年 | 411篇 |
2013年 | 532篇 |
2012年 | 779篇 |
2011年 | 789篇 |
2010年 | 417篇 |
2009年 | 366篇 |
2008年 | 549篇 |
2007年 | 497篇 |
2006年 | 436篇 |
2005年 | 376篇 |
2004年 | 313篇 |
2003年 | 248篇 |
2002年 | 202篇 |
2001年 | 31篇 |
2000年 | 13篇 |
1999年 | 23篇 |
1998年 | 29篇 |
1997年 | 27篇 |
1996年 | 23篇 |
1995年 | 18篇 |
1994年 | 4篇 |
1993年 | 6篇 |
1992年 | 8篇 |
1991年 | 5篇 |
1990年 | 7篇 |
1989年 | 4篇 |
1988年 | 3篇 |
1987年 | 4篇 |
1986年 | 6篇 |
1985年 | 5篇 |
1984年 | 2篇 |
1983年 | 3篇 |
1981年 | 3篇 |
1977年 | 4篇 |
1976年 | 1篇 |
1974年 | 1篇 |
1972年 | 1篇 |
1967年 | 2篇 |
1966年 | 1篇 |
1931年 | 1篇 |
排序方式: 共有8584条查询结果,搜索用时 15 毫秒
61.
62.
Rosa A González-Polo José M Bravo-San Pedro Rubén Gómez-Sánchez Elisa Pizarro-Estrella Mireia Niso-Santano José M Fuentes 《British journal of pharmacology》2013,168(1):60-62
Huntington''s disease (HD) is a neurodegenerative disorder caused by a mutation in the gene encoding the huntingtin protein. Although the precise mechanism by which neuronal degeneration occurs is still unclear, several elements are important to its development: (1) altered gene expression and protein synthesis, (2) mitochondrial damage and (3) improper regulation of the autophagy programme. In this issue of British Journal of Pharmacology, Galindo and co-workers provide the first evidence for a role of the mitochondrial permeability transition pore (mPTP) in mitochondrial fragmentation and autophagy activation. In a model of cell death induced by 3-nitropropionic acid (3-NP) in human neural cells, the authors describe clear functions for mPTP and Bax, but not the mitochondrial fusion/fission machinery, mitochondrial fragmentation and autophagy (mitophagy). This commentary summarises the significance of this relationship and suggests several points for future development. 相似文献
63.
64.
Cancer cells undergo genetic changes allowing their adaptation to environmental changes, thereby obtaining an advantage during the long metastatic route, disseminated of several changes in the surrounding environment. In particular, plasticity in cell motility, mainly due to epigenetic regulation of cancer cells by environmental insults, engage adaptive strategies aimed essentially to survive in hostile milieu, thereby escaping adverse sites. This review is focused on tumor microenvironment as a collection of structural and cellular elements promoting plasticity and adaptive programs. We analyze the role of extracellular matrix stiffness, hypoxia, nutrient deprivation, acidity, as well as different cell populations of tumor microenvironment. 相似文献
65.
Luca Arcaini Michele Merli Francesco Passamonti Raffaele Bruno Ercole Brusamolino Paolo Sacchi Sara Rattotti Ester Orlandi Elisa Rumi Virginia Ferretti Silvia Rizzi Erika Meli Cristiana Pascutto Marco Paulli Mario Lazzarino 《American journal of hematology》2010,85(1):46-50
We studied 160 Hepatitis C virus (HCV)‐positive patients with NHL (59 indolent NHL, 101 aggressive). Median age was 67 years. HCV‐RNA was present in 146. HBsAg was positive in seven patients. At diagnosis, ALT value was above UNL in 67 patients. One hundred and twenty patients received an anthracycline‐based therapy, alkylators, 28 received chemotherapy plus rituximab. Cytotoxic drugs dose was reduced in 63 patients. Among 93 patients with normal ALT at presentation, 16 patients developed WHO grade II–III liver toxicity. Among 67 patients with abnormal ALT, eight patients had a 3.5 times elevation during treatment. Among 28 patients treated with rituximab and chemotherapy, five patients (18%) developed liver toxicity. Thirty four patients (21%) did not complete treatment (eight for liver toxicity). Median progression‐free survival (PFS) for patients who experienced liver toxicity is significantly shorter than median PFS of patients without toxicity (respectively, 2 years and 3.7 years, P = 0.03). After a median F‐UP of 2 years, 32 patients died (three for hepatic failure). A significant proportion of patients with HCV+ NHL develop liver toxicity often leading to interruption of treatment. This could be a limit to the application of immunochemotherapy programs. HCV+ lymphomas represent a distinct clinical subset of NHL that deserves specific clinical approach to limit liver toxicity and ameliorate survival. Am. J. Hematol., 2010. © 2009 Wiley‐Liss, Inc. 相似文献
66.
67.
Romina F. Aromando Elisa M. Heber Verónica A. Trivillin David W. Nigg Amanda E. Schwint María E. Itoiz 《Journal of oral pathology & medicine》2009,38(5):448-454
Objective: The therapeutic success of different boron neutron capture therapy (BNCT) protocols employing the hamster cheek pouch oral cancer model has been previously reported by our laboratory. The aim of this study was to explore potential mechanisms of BNCT‐induced damage to tumor in terms of potential inhibition in DNA synthesis and induction of apoptosis in the tumors that underwent partial remission following application of the different BNCT protocols in this model. Materials and methods: We evaluated DNA synthesis employing incorporation of 5‐bromo‐2′‐deoxyuridine as an end‐point. Apoptosis was evaluated by immunohistochemistry employing the deoxynucleotidyl transferase‐mediated deoxyuridine triphosphate‐biotin nick end‐labeling technique and Bax and Bcl‐2 labeling. These studies were performed in tumors that underwent partial remission 1–30 days post‐BNCT mediated by boronophenylalanine (BPA), GB‐10 (Na210B10H10) or (BPA + GB‐10). Results: BNCT exerted a marked inhibitory effect on DNA synthesis in tumors for all the protocols under study. The inhibitory effect of BPA‐BNCT occurred as soon as 1 day post‐treatment (P < 0.001). Conversely, the effect of GB‐10‐BNCT became apparent 7–14 days after therapy (P < 0.001) and was sustained until killed at 30 days post‐treatment (P < 0.001). (GB‐10 + BPA)‐BNCT exerted a rapid and persistent effect, conceivably because of the combined effect of BNCT mediated by both boron compounds. The apoptosis studies did not show differences between the pre‐treatment group and any of the BNCT groups. Conclusions: One of the mechanisms involved in BNCT‐induced tumor control in our model would be an inhibitory effect on DNA synthesis. Apoptosis does not seem to have a significant role in BNCT‐induced tumor control in our model. 相似文献
68.
Infantile hemangioma is a vascular tumor that occurs in 5–10% of infants of European descent. A defining feature of infantile
hemangioma is the dramatic growth and development into a disorganized mass of blood vessels. Subsequently, a slow spontaneous
involution begins around 1 year of age and continues for 4–6 years. The growth and involution of infantile hemangioma is very
different from other vascular tumors and vascular malformations, which do not regress and can occur at any time during childhood
or adult life. Much has been learned from careful study of the tissue morphology and gene expression patterns during the life-cycle
of hemangioma. Tissue explants and tumor-derived cell populations have provided further insight to unravel the cellular and
molecular basis of infantile hemangioma. A multipotent progenitor cell capable of de novo blood vessel formation has been
isolated from infantile hemangioma, which suggests that this common tumor of infancy, long considered to be a model for pathologic
angiogenesis, may also represent pathologic vasculogenesis. Whether viewed as angiogenesis or vasculogenesis, infantile hemangioma
represents a vascular perturbation during a critical period of post-natal growth, and as such provides a unique opportunity
to decipher mechanisms of human vascular development. 相似文献
69.
Claudio Pratola Elisa Baldo Pasquale Notarstefano Toselli Tiziano Roberto Ferrari 《Journal of interventional cardiac electrophysiology》2006,16(2):111-116
Background Radiofrequency ablation of fast and unstable left ventricular tachycardia (VT) usually requires non-contact mapping. The procedure is usually performed by a retrograde-transaortic route, requiring a double femoral artery puncture, for the 9F multielectrode catheter and the 7F ablation catheter which are advanced through the aorta and aortic valve into the left ventricle (LV). Reported limitations of the procedure are due to the stiffness of the balloon catheter, particularly in patients with tortuous peripheral arteries, atherosclerotic aorta, or with aortic stenosis. The aim of our study was to test the feasibility and assess the safety of a transseptal approach for left VT non-contact mapping and ablation.Materials and methods Ten patients with multiple cardiac defibrillator shocks because of fast and unstable VT were selected for non-contact mapping and ablation. After a double transseptal puncture the multielectrode catheter (Ensite Array™, St. Jude Medical) was advanced through a standard 10F introducer to a stable position in the LV apex over a 260 cm length 0.035 J-tip guidewire. The ablation catheter (Celsius™ Thermo-cool, Biosense Webster) was then inserted through the second 8F introducer. Twenty-five monomorphic sustained ventricular tachycardia were induced and ablated at the level of the diastolic pathway or exit point revealed by unipolar isopotential mapping. The total procedural and fluoroscopy times were 209 ± 32 min and 28.5 ± 9.27 min, respectively, which were comparable to those described with the traditional retrograde-transaortic approach. No major complication related with the transseptal approach were reported.Conclusion A transseptal approach can be a feasible and effective alternative approach for mapping and ablation of fast and unstable left VT with a non-contact mapping system. 相似文献
70.
Kushwaha RS Hayne D Vaizey CJ Wrightham E Payne H Boulos PB 《Diseases of the colon and rectum》2003,46(9):1182-1188
INTRODUCTION: The effect of pelvic radiotherapy on anorectal function is not clearly documented and is investigated in this prospective study. METHODS: Thirty-one males (median age, 70 years) with carcinoma of the prostate (n = 28) and bladder (n = 3) completed proctitis/incontinence symptom score questionnaires and anorectal physiology studies before and six weeks after pelvic radiotherapy. At six months after completion of radiotherapy, 25 of these patients were studied again. The results were expressed as medians and ranges and compared by the Mann-Whitney U test (2-tailed). RESULTS: Six weeks and six months after treatment, respectively, the proctitis symptom scores (0 (0-4) vs. 2 (0-7) (P < 0.001) vs. 2 (0-5) (P < 0.001)) and the incontinence symptom scores (0 (0-5) vs. 4 (0-11) (P < 0.001) vs. 3 (0-14) (P < 0.001)) increased. Urgency, frequency of defecation, anorectal pain, incontinence to liquid stool and to flatus, and alteration in lifestyle were significant symptoms after treatment. The following measurements decreased: anal canal resting pressure (83 (35-137) vs. 79 (26-152) (P = NS) vs. 71 (29-97) (P < 0.01) cm H2O), the squeeze increment (152 (51-135) vs. 162 (63-321) (P = NS) vs. 108 (45-296) (P < 0.042) cm H2O), and the maximum tolerated rectal volume (245 (115-450) vs. 194 (112-344) (P < 0.05) vs. 200 (109-350) (P < 0.138) ml). The rectal electrosensory threshold increased (20 (5.4-44) vs. 22 (9-50.5) (P < 0.134) vs. 31.5 (13.6-76) (P < 0.001) mA). CONCLUSIONS: Anorectal symptoms at six weeks after pelvic radiotherapy are related to reduced rectal capacity and compounded at six months by diminished internal and external sphincter function and rectal mucosal sensitivity. 相似文献